M2-like TAMs were found to increase in recurrent malignant glioma significantly and the M2-like TAMs could activate the PI3K/Akt/HIF-1α/CA9 pathway in the malignant glioma cells via SPP1-CD44-mediated intercellular interaction. This evidence concerns the gene CA9 and malignant glioma.